Literature DB >> 23487849

Abiraterone and castration-resistant prostate cancer.

Talha Khan Burki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23487849     DOI： 10.1016/s1470-2045(12)70585-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Advances in androgen receptor targeted therapy for prostate cancer.

Authors:  Alia Ahmed; Shadan Ali; Fazlul H Sarkar
Journal:  J Cell Physiol       Date:  2014-03       Impact factor: 6.384

2.  N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer.

Authors:  Qunying Wu; Xing Xie; Yiming Huang; Shanshan Meng; Youcheng Li; Huifeng Wang; Yanling Hu
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.